- Home
- KROS vs FRPH Comparison
KROS vs FRPH Comparison
Compare KROS & FRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KROS | FRPH |
|---|---|---|
| Founded | 2015 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 655.9M | 435.3M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | KROS | FRPH |
|---|---|---|
| Price | $18.86 | $24.12 |
| Analyst Decision | Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $22.20 | N/A |
| AVG Volume (30 Days) | ★ 503.5K | 67.4K |
| Earning Date | 02-25-2026 | 03-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.57 | 0.24 |
| Revenue | ★ $246,718,000.00 | $33,049,999.00 |
| Revenue This Year | $6,924.79 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $12.23 | $99.95 |
| Revenue Growth | ★ 37798.31 | 5.21 |
| 52 Week Low | $9.12 | $21.68 |
| 52 Week High | $22.55 | $31.99 |
Technical Indicators
Market Signals| Indicator | KROS | FRPH |
|---|---|---|
| Relative Strength Index (RSI) | 45.72 | 62.65 |
| Support Level | $18.48 | $23.10 |
| Resistance Level | $19.67 | $24.62 |
| Average True Range (ATR) | 0.74 | 0.48 |
| MACD | -0.12 | 0.17 |
| Stochastic Oscillator | 38.08 | 78.67 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).